Literature DB >> 2983205

Antibody to lymphadenopathy-associated virus in AIDS.

D D Ho, T R Rota, M S Hirsch.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2983205     DOI： 10.1056/NEJM198503073121015

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  15 in total

1.  Neutralizing antibodies and antigens in AIDS.

Authors:  S G Norley; R Kurth
Journal:  Infection       Date:  1991       Impact factor: 3.553

2.  Characterization and large production of human monoclonal antibodies against the HIV-1 envelope.

Authors:  V Boyer; H Broly; S Souche; P Madaule; J Rossier; D Zagury; C Desgranges
Journal:  Clin Exp Immunol       Date:  1991-03       Impact factor: 4.330

3.  Detection of antibodies to HTLV-III in commercially available immunoglobulin preparations.

Authors:  R Kurth; I Schmidt; A Werner; G von Wangenheim; J Löwer; H D Brede
Journal:  Klin Wochenschr       Date:  1986-04-15

4.  Short communication: neutralizing antibodies in HIV-1-infected Brazilian individuals.

Authors:  Dalziza Victalina Almeida; Mariza Gonçalvez Morgado; Fernanda Heloise Côrtes; Monick Lindermeyer Guimarães; Leila Mendonça-Lima; Jose Henrique Pilotto; Beatriz Grinsztejn; Valdiléa Gonçalves Veloso; Vera Bongertz
Journal:  AIDS Res Hum Retroviruses       Date:  2012-12-18       Impact factor: 2.205

5.  Application of a rapid microplaque assay for determination of human immunodeficiency virus neutralizing antibody titers.

Authors:  C V Hanson; L Crawford-Miksza; H W Sheppard
Journal:  J Clin Microbiol       Date:  1990-09       Impact factor: 5.948

6.  Identification of human immunodeficiency virus subtypes with distinct patterns of sensitivity to serum neutralization.

Authors:  C Cheng-Mayer; J Homsy; L A Evans; J A Levy
Journal:  Proc Natl Acad Sci U S A       Date:  1988-04       Impact factor: 11.205

7.  Persistent infection of chimpanzees with human T-lymphotropic virus type III/lymphadenopathy-associated virus: a potential model for acquired immunodeficiency syndrome.

Authors:  P N Fultz; H M McClure; R B Swenson; C R McGrath; A Brodie; J P Getchell; F C Jensen; D C Anderson; J R Broderson; D P Francis
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

8.  Human monoclonal antibody that recognizes the V3 region of human immunodeficiency virus gp120 and neutralizes the human T-lymphotropic virus type IIIMN strain.

Authors:  C F Scott; S Silver; A T Profy; S D Putney; A Langlois; K Weinhold; J E Robinson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-11       Impact factor: 11.205

9.  Neutralizing antibodies in HIV (HTLV-III) infection: correlation with clinical outcome and antibody response against different viral proteins.

Authors:  A Ranki; S H Weiss; S L Valle; J Antonen; K J Krohn
Journal:  Clin Exp Immunol       Date:  1987-08       Impact factor: 4.330

10.  Restricted neutralization of divergent human T-lymphotropic virus type III isolates by antibodies to the major envelope glycoprotein.

Authors:  T J Matthews; A J Langlois; W G Robey; N T Chang; R C Gallo; P J Fischinger; D P Bolognesi
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.